"10.1371_journal.pone.0040466","plos one","2012-07-10T00:00:00Z","Andrew Stone; Fatima Valdés-Mora; Julia M W Gee; Lynne Farrow; Richard A McClelland; Heidi Fiegl; Carol Dutkowski; Rachael A McCloy; Robert L Sutherland; Elizabeth A Musgrove; Robert I Nicholson","Welsh School of Pharmacy, Redwood Building, Cardiff University, Cardiff, Wales, United Kingdom; The Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Sydney, New South Wales, Australia; Department of Epigenetics, Garvan Institute of Medical Research, Sydney, New South Wales, Australia; Department of Gynaecology and Obstetrics, Innsbruck Medical University, Innsbruck, Austria; St Vincent’s Clinical School, Faculty of Medicine, University of New South Wales, St Vincent’s Hospital, Sydney, New South Wales, Australia","Conceived and designed the experiments: AS. Performed the experiments: AS FVM RAM HF CD RAM. Analyzed the data: AS JMWG FVM LF. Contributed reagents/materials/analysis tools: FVM JMWG RIN EAM RLS. Wrote the paper: AS. Oversaw the project: RIN JMWG RLS EAM.","The authors declare that they have no competing interests that would prejudice the impartiality of this scientific work. Although two of the authors (Julia Gee and Robert Nicholson) were in receipt of funding from AstraZeneca, this does not alter the authors’ adherence to all PLoS ONE policies on sharing data and materials, as detailed online in the PLoS ONE guide for authors. AstraZeneca have no commercial or financial interest in this body of work and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","2012","07","Andrew Stone","AS",11,FALSE,1,5,4,1,TRUE,TRUE,FALSE,0,NA,FALSE
